SEC23B Activators

SEC23B Activators refer to the class of compounds that can influence the activity of SEC23B, a crucial component of the COPII complex involved in protein transport from the endoplasmic reticulum (ER) to the Golgi apparatus. These compounds do not directly activate SEC23B but rather exert their effects through indirect mechanisms, primarily through the induction of ER stress and the disruption of normal cellular processes that subsequently require SEC23B activation for resolution. For instance, brefeldin A and monensin disrupt the structure and ion balance of the Golgi apparatus, respectively, thereby indirectly activating SEC23B to restore normal protein transport. Similarly, nigericin, which disrupts ion gradients, also activates SEC23B indirectly. Thapsigargin, tunicamycin, DTT, MG132, ALLN, and eeyarestatin I are all compounds that induce ER stress through various mechanisms, such as inhibition of the SERCA pump, prevention of N-linked glycosylation, inhibition of the proteasome, and prevention of ER-associated degradation, respectively. These ER stress inducers thereby indirectly activate SEC23B, which plays a critical role in managing misfolded proteins and maintaining protein transport under such conditions.

Other compounds, such as 2-deoxyglucose, tauroursodeoxycholic acid, and 4-phenylbutyric acid, can influence SEC23B activity through their effects on glycolysis or ER stress attenuation. Particularly, 2-deoxyglucose, an inhibitor of glycolysis, can induce ER stress and thereby indirectly activate SEC23B. On the other hand, tauroursodeoxycholic acid and 4-phenylbutyric acid, both known for their roles in alleviating ER stress, may modulate SEC23B activity in the context of ER stress resolution.